<?xml version="1.0" encoding="UTF-8"?>
<article article-type="research-article" xml:lang="en" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher">global-journal-of-medical-research-k-interdisciplinary</journal-id>
<journal-title-group>
<journal-title>Global Journal of Medical Research - K: Interdisciplinary</journal-title>
</journal-title-group>
<issn publication-format="print">0975-5888</issn>
<issn publication-format="electronic">2249-4618</issn>
<publisher><publisher-name>Global Journals Publishing Group Incorporated</publisher-name></publisher>
<self-uri xlink:href="https://globaljournals.org/journal-seo-export/jats/60091.xml" />
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">60091</article-id>
<title-group>
<article-title>Mucosal-Invariant T Cell Receptor Recognizes HLA-DRB1 Selected SARS-Epitopes</article-title>
<subtitle>HLA-DRB1 and MAIT-TCR Binding of Spike Epitopes</subtitle>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Dasgupta</surname><given-names>Subhajit</given-names></name><xref ref-type="aff" rid="aff1" />
</contrib>
<contrib contrib-type="author"><name><surname>Dasgupta</surname><given-names>Shaoni ,</given-names></name></contrib>
<contrib contrib-type="author"><name><surname>Bandyopadhyay</surname><given-names>Mausumi</given-names></name></contrib>
</contrib-group>
<aff id="aff1">UNITED STATES</aff>
<pub-date publication-format="electronic" date-type="pub" iso-8601-date="2023-04-21">
<day>21</day>
<month>04</month>
<year>2023</year>
</pub-date>
<volume>23</volume>
<issue>K2</issue>
<fpage>1</fpage>
<lpage>14</lpage>
<abstract><p>Infection of SARS-COV2 and its variants causes wide range morbidity and mortality in recent years. Identification of epitope-based mechanism of viral infection with progressive fatality and antiviral immunotherapy are two major goals to address population-bias immune response. We selected peptides from SARS-COV2 Spike (6VXX_A), Delta (B.1.617.2), Omicron (B.1.1.529) proteins. These peptides contain epitopes which are identified as low rank good fit immunogenic as recognized more by HLA-DRB1*15:01, than HLA-DRB1*07:01 and HLA-DRB1*03:01. We also found the selected epitopes specifically form interactive complex with mucosa-associated invariant T cell. The Molecular Docking and Molecular Dynamics experiments demonstrated amino acid sequence-specific interaction between close atoms from epitopes and MAIT-TCR. We used virus unrelated microbial peptide antigen85 as control.</p></abstract>
<kwd-group kwd-group-type="author-generated">
<kwd>SARCOV2; Spike peptides; Epitope; HLA-DR; T cell</kwd>
<kwd>T cell receptor</kwd>
<kwd>mucosa.</kwd>
</kwd-group>
<self-uri content-type="pdf" xlink:href="https://globaljournals.org/GJMR_Volume23/1-Mucosal-Invariant-T-Cell-Receptor-Recognizes.pdf" />
<self-uri content-type="html" xlink:href="https://globaljournals.org/scholarly-articles/mucosal-invariant-t-cell-receptor-recognizes-hla-drb1-selected-sars-epitopes/" />
</article-meta>
</front>
<body>
<sec>
<title>Full Text</title>
<p>Infection of SARS-COV2 and its variants causes wide range morbidity and mortality in recent years. Identification of epitope-based mechanism of viral infection with progressive fatality and antiviral immunotherapy are two major goals to address population-bias immune response. We selected peptides from SARS-COV2 Spike (6VXX_A), Delta (B.1.617.2), Omicron (B.1.1.529) proteins. These peptides contain epitopes which are identified as low rank good fit immunogenic as recognized more by HLA-DRB1*15:01, than HLA-DRB1*07:01 and HLA-DRB1*03:01. We also found the selected epitopes specifically form interactive complex with mucosa-associated invariant T cell. The Molecular Docking and Molecular Dynamics experiments demonstrated amino acid sequence-specific interaction between close atoms from epitopes and MAIT-TCR. We used virus unrelated microbial peptide antigen85 as control.</p>
</sec>
</body>
</article>